全文获取类型
收费全文 | 14289篇 |
免费 | 1011篇 |
国内免费 | 223篇 |
专业分类
耳鼻咽喉 | 216篇 |
儿科学 | 120篇 |
妇产科学 | 151篇 |
基础医学 | 2365篇 |
口腔科学 | 275篇 |
临床医学 | 1348篇 |
内科学 | 2626篇 |
皮肤病学 | 484篇 |
神经病学 | 1015篇 |
特种医学 | 1233篇 |
外科学 | 1751篇 |
综合类 | 46篇 |
一般理论 | 3篇 |
预防医学 | 432篇 |
眼科学 | 228篇 |
药学 | 1816篇 |
中国医学 | 267篇 |
肿瘤学 | 1147篇 |
出版年
2024年 | 2篇 |
2023年 | 87篇 |
2022年 | 76篇 |
2021年 | 542篇 |
2020年 | 310篇 |
2019年 | 464篇 |
2018年 | 550篇 |
2017年 | 462篇 |
2016年 | 644篇 |
2015年 | 861篇 |
2014年 | 1009篇 |
2013年 | 1090篇 |
2012年 | 1465篇 |
2011年 | 1492篇 |
2010年 | 892篇 |
2009年 | 673篇 |
2008年 | 879篇 |
2007年 | 843篇 |
2006年 | 690篇 |
2005年 | 635篇 |
2004年 | 555篇 |
2003年 | 402篇 |
2002年 | 312篇 |
2001年 | 167篇 |
2000年 | 135篇 |
1999年 | 79篇 |
1998年 | 41篇 |
1997年 | 23篇 |
1996年 | 23篇 |
1995年 | 11篇 |
1994年 | 12篇 |
1993年 | 7篇 |
1992年 | 22篇 |
1991年 | 14篇 |
1990年 | 13篇 |
1989年 | 11篇 |
1988年 | 6篇 |
1987年 | 3篇 |
1986年 | 8篇 |
1985年 | 6篇 |
1983年 | 3篇 |
1977年 | 1篇 |
1976年 | 2篇 |
1974年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Sleep and Breathing - The presence of periodic limb movements during sleep (PLMS) varies among patients with obstructive sleep apnea (OSA) undergoing treatment with continuous positive airway... 相似文献
3.
Kim Jung Wan Eom Youngsub Park Wonkyung Song Jong Suk Jeong Ji Won Park Seh Kwang Kim Hyo Myung 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2022,260(10):3275-3283
Graefe's Archive for Clinical and Experimental Ophthalmology - To compare visual outcomes between two types of mix-and-match implanted trifocal extended-depth-of-focus (EDoF) and trifocal... 相似文献
4.
5.
6.
7.
Soo Jin Kim Kyung Hwan Jegal Ji-Hye Im Gyutae Park Suntae Kim Hye Gwang Jeong Il Je Cho Keon Wook Kang 《Cancer chemotherapy and pharmacology》2020,85(4):685-697
CKD-516 (Valecobulin), a vascular-disrupting agent, inhibits microtubule elongation. We evaluated the effect of CKD-516 on lung cancer cells and the underlying molecular mechanisms. The effects of S516, an active metabolite of CKD-516, were evaluated in HUVECs and three lung cancer cell lines and by a microtubule polymerization assay. Tubulin cross-linking was used to identify the binding site of S516 on tubulin, and Western blotting was performed to identify the intracellular pathways leading to cell death. Subcutaneous lung cancer xenograft models were used to assess the in vivo effect of CKD-516 on tumor growth. S516 targeted the colchicine binding site on β-tubulin. In lung cancer cells, S516 increased endoplasmic reticulum (ER) stress and induced reactive oxygen species (ROS) generation by mitochondria and the ER. In addition, CKD-516 monotherapy strongly inhibited the growth of lung cancer xenograft tumors and exerted a synergistic effect with carboplatin. The findings suggest that CKD-516 exerts an anticancer effect in company with inducing ER stress and ROS production via microtubule disruption in lung cancer cells. CKD-516 may thus have therapeutic potential for lung cancer. 相似文献
8.
9.
Young Hyo Choi Min Yong Kang Hyun Hwan Sung Hwang Gyun Jeon Byong Chang Jeong Seong Il Seo Seong Soo Jeon Chan Kyo Kim Byung Kwan Park Hyun Moo Lee 《Clinical genitourinary cancer》2019,17(1):e19-e25
Background
The purpose of the study was to compare cancer detection rates between 12-core transrectal ultrasound-guided prostate biopsy (TRUS-Bx) and multiparametric magnetic resonance imaging (mpMRI)-guided target prostate biopsy (MRI-TBx) according to prostate-specific antigen (PSA) level in biopsy-naive patients.Patients and Methods
A retrospective study was conducted in 2009 biopsy-naive patients with suspected prostate cancer (PSA ≤20 ng/mL). Patients underwent TRUS-Bx (n = 1786) or MRI-guided target prostate biopsy (MRI-TBx; n = 223) from September 2013 to March 2017 and were stratified according to each of 4 PSA cutoffs. MRI-TBx was performed on lesions with Prostate Imaging Reporting and Data System (PI-RADS) scores of 3 to 5 on mpMRI. Clinically significant prostate cancer (csPCa) was defined as Gleason ≥7. Propensity score matching was performed using the prebiopsy variables, which included age, PSA, prostate volume, and PSA density.Results
Propensity score matching resulted in 222 patients in each group. There were significant differences between the TRUS-Bx and MRI-TBx groups in the overall detection rates of prostate cancer (41.4% vs. 55.4%; P = .003) and csPCa (30.1% vs. 42.8%; P = .005). However, across PSA cutoffs, MRI-TBx detected more prostate cancer than TRUS-Bx at PSA levels of 2.5 to <4 (29.5% vs. 56.6%; P < .001). The csPCa detection rates of TRUS-Bx and MRI-TBx did not differ significantly within the PSA cutoffs. There was a significantly higher detection rate of prostate cancer and csPCa in lesions with PI-RADS scores 4 and 5 than in those with a score of 3.Conclusion
Prebiopsy mpMRI and subsequent targeted biopsy had a higher detection rate than TRUS-Bx in patients with prostate cancer and csPCa. 相似文献10.
Choi Kwang-Dong Choi Seo Young Choi Jae-Hwan Kim Seong Hi Lee Seong-Han Jeong Seong-Hae Kim Hyo-Jung Choi Jeong-Yoon Kim Ji-Soo 《Journal of neurology》2019,266(2):476-479
Journal of Neurology - To define the prevalence and characteristics of single ocular motor nerve palsy (OMNP) associated with positive serum anti-GQ1b antibody. We performed a prospective... 相似文献